PHAT
Phathom Pharmaceuticals Inc
7.50$
-3.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +3,937.5% | +61.3% | +19.0% | -7.3% | +38.3% | -20.4% | |
| – | – | +1,338.4% | +187.9% | +43.5% | +86.6% | -46.6% | +19.4% | |
| – | +455,352.0% | -97.3% | +207.0% | +131.0% | – | – | – | |
| – | -4,528.8% | – | -152.8% | – | -350.9% | – | – | |
| – | +19,028.8% | -95.9% | -68.5% | +217.4% | +57.0% | -91.7% | +69.6% | |
| – | +0.0% | -95.9% | -68.5% | +217.4% | +57.0% | -91.7% | +69.6% | |
| – | +9,573,500.0% | -99.7% | +209.1% | – | – | – | – | |
| – | +5,856.5% | -77.9% | +71.1% | +123.2% | -58.8% | +51.1% | -100.0% | |
| – | +15,917.1% | -62.4% | -60.9% | +168.5% | +206.2% | -50.3% | -100.2% | |
| – | +27,532.1% | -82.0% | -338.0% | – | – | -136.8% | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.